Markets:

Overview

News

Currencies

International

Treasuries

Pharvaris N.V. - Ordinary Shares (NQ:PHVS)

24.54 +0.57 (+2.38%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pharvaris N.V. - Ordinary Shares

< Previous 1 2 3 Next >

Biotech Stock Gets Booted in Latest Fund Update ↗

November 19, 2025

Bain Capital sold its entire stake in Nuvalent stock during the third quarter.

Via The Motley Fool

Topics Regulatory Compliance

Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock ↗

November 19, 2025

Bain Capital completely exited its position in Disc Medicine stock during the third quarter

Via The Motley Fool

5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗

November 18, 2025

One major biotech investor just walked away from Viking Therapeutics. Here’s what the move may—and may not—mean for the company’s clinical-stage future.

Via The Motley Fool

Topics Regulatory Compliance

Analyst Expectations for Pharvaris's Future ↗

December 07, 2023

Via Benzinga

5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out ↗

November 18, 2025

A major biotech investor just walked away from MoonLake after a rough year for the stock. Here’s what that move signals—and what long-term investors should keep an eye on next.

Via The Motley Fool

Why Bain Capital Is Selling Shares of This Biotech Stock Now ↗

November 18, 2025

Bain Capital sold $20 million worth of Pharvaris stock during the third quarter.

Via The Motley Fool

Topics Regulatory Compliance

This Uber Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

October 15, 2025

Via Benzinga

Pharvaris NV (NASDAQ:PHVS) Reports Wider Q2 2025 Loss, Highlights Clinical Trial Progress ↗

August 12, 2025

Pharvaris NV (PHVS) reported a Q2 2025 loss of €0.83/share, missing estimates. Revenue was nil as R&D spend rose. Focus remains on Phase 3 trials for deucrictibant in HAE/AAE-C1INH, with key data...

Via Chartmill

PHVS Stock Earnings: Pharvaris Beats EPS for Q2 2024 ↗

August 14, 2024

PHVS stock results show that Pharvaris beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense ↗

July 16, 2024

Biogen has $8 billion to $10 billion in dry powder for acquisitions. Here are three names the company could examine.

Via Investor's Business Daily

PHVS Stock Earnings: Pharvaris Misses EPS for Q1 2024 ↗

May 08, 2024

PHVS stock results show that Pharvaris missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

PHVS Stock Earnings: Pharvaris Misses EPS for Q4 2023 ↗

April 10, 2024

PHVS stock results show that Pharvaris missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Top-Notch Pharvaris Eyes Profit-Taking Zone On A Key FDA Decision ↗

January 22, 2024

The company is working on a treatment for swelling attacks associated with a genetic disease.

Via Investor's Business Daily

FDA Clears Pharvaris' Trial For Investigational Drug For Swollen Blood Vessels, Stock Jumps ↗

January 22, 2024

Pharvaris receives FDA approval to advance deucrictibant for hereditary angioedema prophylaxis, lifting clinical hold. Learn about the latest developments in HAE treatment.

Via Benzinga

Gold Moves Higher; Campbell Soup Earnings Top Expectations ↗

December 06, 2023

U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.

Via Benzinga

Topics Stocks

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 06, 2023

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Via Benzinga

Turnaround For Pharvaris Since FDA Clinical Hold - Data Shows Its Oral Hereditary Angioedema Treatment Cuts Attacks ↗

December 06, 2023

Pharvaris NV (NASDAQ: PHVS) released topline data from the CHAPTER-1 Phase 2 study meeting its primary endpoint, with deucrictibant demonstrating statistically significant and clinically meaningful...

Via Benzinga

Crude Oil Down 4%; Pharvaris Shares Spike Higher ↗

December 06, 2023

U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,...

Via Benzinga

Topics Stocks

AMD Stock Alert: What to Expect From Advanced Micro Devices ‘Advancing AI’ Event ↗

December 06, 2023

Advanced Micro Devices stock is climbing higher on Wednesday as AMD investors prepare for the company's Advancing AI event today.

Via InvestorPlace

Topics Artificial Intelligence

THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday ↗

December 06, 2023

U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday.

Via Benzinga

Topics Stocks

Shopify (SHOP) Stock Falls Following Analyst Downgrade ↗

December 06, 2023

Shopify stock is taking a beating on Wednesday after shares of SHOP were hit with a downgrade from Wedbush analyst Scott Devitt.

Via InvestorPlace

Why Is Pharvaris (PHVS) Stock Up 36% Today? ↗

December 06, 2023

Pharvaris stock is rising higher on Wednesday following news of an underwritten offering for PHVS shares and pre-funded warrants.

Via InvestorPlace

US Stocks Higher; Private Payrolls Rise By 103,000 In November ↗

December 06, 2023

U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%...

Via Benzinga

Topics Stocks

Pharvaris' Promising Oral Treatment Solutions For Treating Swollen Blood Vessels - Analyst Sees 35% Upside ↗

September 25, 2023

Wedbush has initiated coverage on Pharvaris N.V. (NASDAQ: PHVS), noting that the company stands out as one of the players with their strategy to develop and advance oral therapeutic options in both the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023 ↗

September 25, 2023

Via Benzinga

Smucker, FuelCell Energy, Granite Ridge Resources And Other Big Stocks Moving Lower On Monday ↗

September 11, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording losses in today’s session. IHS Holding Limited (NYSE: IHS) shares fell 15.7% to...

Via Benzinga

Topics Stocks

Farfetch, Faraday Future Intelligent Electric, VinFast, And Other Stocks Moving Lower On Friday ↗

August 18, 2023

U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 ↗

August 15, 2023

Via Benzinga

Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 15, 2023

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.

Via Benzinga

Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday ↗

August 15, 2023

U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.